2022. Post-COVID-19 Guillain-Barre syndrome with good response to intravenous immunoglobulin. Indian Journal of Case Reports. 8, 7 (Aug. 2022), 232–233. DOI:https://doi.org/10.32677/ijcr.v8i7.3361.